Enhanced serum interferon-lambda 1/interleukin-29 levels in patients with psoriasis vulgaris
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced serum interferon-lambda 1/interleukin-29 levels in patients with psoriasis vulgaris
Authors
Keywords
Interleukins, Leukocytes, mononuclear, Psoriasis
Journal
ANAIS BRASILEIROS DE DERMATOLOGIA
Volume 96, Issue 4, Pages 416-421
Publisher
Elsevier BV
Online
2021-05-24
DOI
10.1016/j.abd.2020.11.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sensitivity and specificity of Interleukin 29 in patients with rheumatoid arthritis and other rheumatic diseases
- (2020) Laurindo Ferreira da Rocha Junior et al. IMMUNOLOGY LETTERS
- Role of regulatory T cells in psoriasis pathogenesis and treatment
- (2020) L. Nussbaum et al. BRITISH JOURNAL OF DERMATOLOGY
- Psoriasis Pathogenesis and Treatment
- (2019) Adriana Rendon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-29 promoted obesity-induced inflammation and insulin resistance
- (2019) Tian-Yu Lin et al. Cellular & Molecular Immunology
- Insights into IL‐29: Emerging role in inflammatory autoimmune diseases
- (2019) Jia‐Min Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
- (2018) Andrew Blauvelt et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis
- (2017) G. Girolomoni et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Interferons and systemic sclerosis: correlation between interferon gamma and interferon-lambda 1 (IL-29)
- (2015) Andréa Tavares Dantas et al. AUTOIMMUNITY
- Interplay between CXCR2 and BLT1 Facilitates Neutrophil Infiltration and Resultant Keratinocyte Activation in a Murine Model of Imiquimod-Induced Psoriasis
- (2014) H. Sumida et al. JOURNAL OF IMMUNOLOGY
- IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients
- (2013) Lingxiao Xu et al. ARTHRITIS RESEARCH & THERAPY
- Type III IFNs Are Produced by and Stimulate Human Plasmacytoid Dendritic Cells
- (2012) Z. Yin et al. JOURNAL OF IMMUNOLOGY
- Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis
- (2012) Fang Wang et al. ARTHRITIS RESEARCH & THERAPY
- Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
- (2011) A. M. Lin et al. JOURNAL OF IMMUNOLOGY
- Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity
- (2011) Qian Wu et al. ARTHRITIS RESEARCH & THERAPY
- Expression and release of IL-29 by mast cells and modulation of mast cell behavior by IL-29
- (2010) S. He et al. ALLERGY
- CD14+ cell-derived IL-29 modulates proinflammatory cytokine production in patients with allergic airway inflammation
- (2010) S. He et al. ALLERGY
- Interferon-λ1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responsesin vitro
- (2008) Shekar Srinivas et al. IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started